Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2020 |
| Author/s |
author: Tadeusz Robak Jacek Trelinski |
| Publication date | September 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |